Literature DB >> 2447696

Chromogranin A and B and secretogranin II in bronchial and intestinal carcinoids.

R Weiler1, H Feichtinger, K W Schmid, R Fischer-Colbrie, L Grimelius, B Cedermark, M Papotti, G Bussolati, H Winkler.   

Abstract

Carcinoid tumours (bronchial and intestinal) were analyzed by immunoblotting for the presence of chromogranin A, B and secretogranin II. In all tumours an antigen corresponding in electrophoretic behaviour to adrenal chromogranin A was present. Lung carcinoids (3 out of 5) contained a relatively high concentration of a proteoglycan form of this antigen in addition. Chromogranin B was found in all tumours. In one and two dimensional immunoblotting it appeared identical to the corresponding adrenal antigen. Secretogranin II was also present, however concentrations (especially in intestinal carcinoids) were low and variable. Furthermore, in intestinal tumours it differed from the adrenal antigen by having a slightly higher molecular size and a more alkaline pI. Immunohistochemistry revealed that the tumour tissues stained positively for all three antigens. For secretogranin II the staining in intestinal tumours was relatively weak and quite variable. These results should provide a defined basis for immunohistochemical screening of carcinoids for the chromogranin/secretogranin antigens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2447696     DOI: 10.1007/bf00716181

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  42 in total

1.  The classification of carcinoid tum ours.

Authors:  E D WILLIAMS; M SANDLER
Journal:  Lancet       Date:  1963-02-02       Impact factor: 79.321

2.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

3.  A nomenclature proposal for the chromogranin/secretogranin proteins.

Authors:  L E Eiden; W B Huttner; J Mallet; D T O'Connor; H Winkler; A Zanini
Journal:  Neuroscience       Date:  1987-06       Impact factor: 3.590

4.  Atypical carcinoid tumors of the lung.

Authors:  M G Arrigoni; L B Woolner; P E Bernatz
Journal:  J Thorac Cardiovasc Surg       Date:  1972-09       Impact factor: 5.209

5.  A neuroendocrine marker in tissues of the immune system.

Authors:  R H Angeletti; W F Hickey
Journal:  Science       Date:  1985-10-04       Impact factor: 47.728

Review 6.  Neuroendocrine cells and neuroendocrine neoplasms of the lung.

Authors:  V E Gould; R I Linnoila; V A Memoli; W H Warren
Journal:  Pathol Annu       Date:  1983

Review 7.  The composition of adrenal chromaffin granules: an assessment of controversial results.

Authors:  H Winkler
Journal:  Neuroscience       Date:  1976       Impact factor: 3.590

8.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

9.  Some chemical and physical properties of the soluble protein fraction of bovine adrenal chromaffin granules.

Authors:  K B Helle
Journal:  Mol Pharmacol       Date:  1966-07       Impact factor: 4.436

10.  Detection of chromogranin in neuroendocrine cells with a monoclonal antibody.

Authors:  B S Wilson; R V Lloyd
Journal:  Am J Pathol       Date:  1984-06       Impact factor: 4.307

View more
  16 in total

Review 1.  Biochemistry of the chromogranin A protein family.

Authors:  J P Simon; D Aunis
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

2.  Undegraded chromogranin A is present in serum and enters the endocytotic lysosomal pathway in kidney.

Authors:  R Weiler; H J Steiner; R Fischer-Colbrie; K W Schmid; H Winkler
Journal:  Histochemistry       Date:  1991

3.  Immunohistochemical demonstration of chromogranin A, chromogranin B, and secretoneurin in primary non-small-cell carcinomas of the lung.

Authors:  Martin Tötsch; Birgit Kunk; Barbara Dockhorn-Dworniczak; Dietmar Öfner; Reiner Fischer-Colbrie; Gregor Mikuz; Werner Böcker; Kurt Werner Schmid
Journal:  Endocr Pathol       Date:  1994-12       Impact factor: 3.943

4.  Antiserum directed against chromogranin A and B (CAB) is a useful marker for peptide hormone-producing endocrine cells and tumors.

Authors:  L Larsson; J Alumets; B Eriksson; R Håkanson; G Lundquist; K Öberg; F Sundler
Journal:  Endocr Pathol       Date:  1992-03       Impact factor: 3.943

Review 5.  The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.

Authors:  P Rosa; H H Gerdes
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

Review 6.  Immunohistochemical Biomarkers of Gastrointestinal, Pancreatic, Pulmonary, and Thymic Neuroendocrine Neoplasms.

Authors:  Silvia Uccella; Stefano La Rosa; Marco Volante; Mauro Papotti
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

7.  Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract.

Authors:  A G Fahrenkamp; C Wibbeke; G Winde; D Ofner; W Böcker; R Fischer-Colbrie; K W Schmid
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  Changes in neuroendocrine elements in bronchial mucosa in chronic lung disease in adults.

Authors:  M Pilmane; A Luts; F Sundler
Journal:  Thorax       Date:  1995-05       Impact factor: 9.139

Review 9.  The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia.

Authors:  Steven A Feldman; Lee E Eiden
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

10.  Immunoreactivities for chromogranin A and B, and secretogranin II in the guinea pig entero-endocrine system: cellular distributions and intercellular heterogeneities.

Authors:  Y Cetin; D Grube
Journal:  Cell Tissue Res       Date:  1991-05       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.